# The Impact of Red Cell Age on Product Utilization in the Chronically Transfused Outpatient Population

> **NCT02393508** · PHASE3 · UNKNOWN · sponsor: **University of Calgary** · enrollment: 60 (estimated)

## Conditions studied

- Bone Marrow Failure Syndrome

## Interventions

- **OTHER:** Fresh Human Red Blood Cells
- **OTHER:** Aged Human Red Blood Cells

## Key facts

- **NCT ID:** NCT02393508
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-09
- **Primary completion:** 2017-03
- **Final completion:** 2017-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2015-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02393508

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02393508, "The Impact of Red Cell Age on Product Utilization in the Chronically Transfused Outpatient Population". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02393508. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*